Samuel D. Waksal
Businessperson, Organization founder
1947 –
Who is Samuel D. Waksal?
Samuel D. "Sam" Waksal, Ph.D., is the founder and former CEO of the biopharmaceutical company ImClone Systems. He is also the founder and CEO of Kadmon Pharmaceuticals which was financed with private capital and commenced operations in New York City in 2010. At ImClone, Waksal led the company to develop the landmark cancer drug Erbitux. During the course of its review process with Food and Drug Administration Waksal became involved in an insider trading scandal revolving around improper communications with personal friends and family members. He was convicted of several securities violations, served time in federal prison, and was released.
We need you!
Help us build the largest biographies collection on the web!
- Born
- Sep 8, 1947
Paris - Also known as
- Samuel Waksal
- Ethnicity
- Jewish people
- Nationality
- United States of America
- Profession
- Education
- Ohio State University
- Lived in
- Paris
Submitted
on July 23, 2013
Citation
Use the citation below to add to a bibliography:
Style:MLAChicagoAPA
"Samuel D. Waksal." Biographies.net. STANDS4 LLC, 2024. Web. 3 May 2024. <https://www.biographies.net/people/en/samuel_d_waksal>.
Discuss this Samuel D. Waksal biography with the community:
Report Comment
We're doing our best to make sure our content is useful, accurate and safe.
If by any chance you spot an inappropriate comment while navigating through our website please use this form to let us know, and we'll take care of it shortly.
Attachment
You need to be logged in to favorite.
Log In